title: Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.
abstract: BACKGROUND
  In a recent case-control study, the odds of metabolic syndrome (MetSyn) among deep vein thrombosis cases were almost twice those among controls. We tested the hypothesis that the incidence of non-cancer-related venous thromboembolism (VTE) is higher among adults with MetSyn and further, that associations are stronger for idiopathic than secondary VTE.
  
  
  METHODS
  A total of 20 374 middle-aged and elderly adults were followed for over 12 years for incident VTE in the Longitudinal Investigation of Thromboembolism Etiology (LITE). All hospitalizations were identified and VTEs validated by chart review. Baseline MetSyn was defined using ATP III guidelines, including >or=3 of the following components: abdominal obesity, elevated blood pressure, low HDL-cholesterol, high triglycerides and high glucose. Because sex modified the relation between MetSyn and VTE (p(interaction) = 0.001), proportional hazards regression analyses were stratified by sex to assess the associations of MetSyn and its components with risk of incident non-cancer-related VTE, adjusting for potential confounders.
  
  
  RESULTS
  Incident VTE (n = 358) included 196 idiopathic events. Baseline MetSyn was associated with risk of total VTE (hazard ratio (HR) = 1.84, 95% CI = 1.30, 2.59) and idiopathic VTE (HR = 1.59, 95% CI = 1.02, 2.47) among men, but not women. The association was largely attributable to abdominal obesity (HR of VTE = 2.10, 95% CI = 1.51, 2.93, in men; HR of VTE = 1.70, 95% CI = 1.24, 2.34, in women), with no additional contribution by the other MetSyn components.
  
  
  CONCLUSIONS
  Although abdominal obesity was associated with increased risk of VTE in both men and women, MetSyn and its other components do not seem important in VTE etiology.
authors.affiliation: Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN 55454, USA. steffen@epi.umn.edu
authors.forename: L M
authors.initials: LM
authors.lastname: Steffen
authors.forename: M
authors.initials: M
authors.lastname: Cushman
authors.forename: J M
authors.initials: JM
authors.lastname: Peacock
authors.forename: S R
authors.initials: SR
authors.lastname: Heckbert
authors.forename: D R
authors.initials: DR
authors.lastname: Jacobs
authors.forename: W D
authors.initials: WD
authors.lastname: Rosamond
authors.forename: A R
authors.initials: AR
authors.lastname: Folsom
mesh_terms: D001779:Blood Coagulation Factors / Q000032:analysis; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D015992:Body Mass Index; D015331:Cohort Studies; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D008055:Lipids / Q000097:blood; D008137:Longitudinal Studies; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D016016:Proportional Hazards Models; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000097:blood / Q000150:complications* / Q000503:physiopathology
chemical_list: D001779:Blood Coagulation Factors; D001786:Blood Glucose; D008055:Lipids; D005340:Fibrinogen